Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Cymbiotika

Explore full profile

Plant-based liposomal supplements for optimal health

San Diego, United StatesFounded 2020Wellness Beauty
Valuation $100–500M Latest valuation · 2025
Revenue $100–500M Latest reported FY
Headcount 100–500 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Cymbiotika and the history behind them.

About Cymbiotika

Cymbiotika is a wellness company that develops and sells plant-based nutritional supplements that blend scientific innovation with traditional Eastern medicine. The company was founded in 2019 by Shahab Elmi, his wife Durana Elmi, and Chervin Jafarieh. The founding was driven by a desire to address a perceived lack of transparency in the wellness industry, a concern that became personal as they sought high-quality products for their own children. The company name signifies the symbiosis between nature and human health.

Read full description

Shahab Elmi, the CEO, is a serial entrepreneur with a PhD in organizational leadership and a background that includes launching and exiting three other businesses before Cymbiotika. His previous ventures include the online radio platform DASH Radio, a national Cricket Wireless dealership, and a customizable phone case company. Durana Elmi, the COO, graduated from UCLA and held corporate roles at T-Mobile and AT&T before her entrepreneurial journey with her husband, co-founding five startups, three of which were successfully acquired. Her Afghan heritage and upbringing in the U.S. have shaped her focus on women's empowerment. Chervin Jafarieh, the Chief Scientific Officer, has a background in biodynamic farming, Ayurveda, and traditional Chinese medicine, and was mentored by health authorities from an early age.

Cymbiotika's business model is direct-to-consumer, primarily driven by online sales and a significant subscription base, which accounts for over 125,000 monthly subscriptions. The company's revenue is generated through the sale of its supplements. After being bootstrapped and profitable for five years, the company secured a $25 million seed round in late 2025 to sustain its rapid growth. The brand has experienced substantial year-over-year growth and has attracted high-profile celebrity investors. A key part of their strategy includes maintaining control over marketing, fulfillment, and customer support in-house.

The company's core offering is a range of sophisticated organic supplements that utilize advanced liposomal technology for enhanced nutrient absorption. This technology is designed to protect nutrients and deliver them more effectively into the body. Their products, which are free from synthetics, GMOs, and fillers, target various health needs such as immunity, gut health, and stress relief. Initially launching with a single DHA omega-3 product, the company has expanded its line to include over 38 different supplements. Cymbiotika has also expanded its retail presence, launching products in stores like The Vitamin Shoppe, Sprouts, and Target.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2020
Headquarters
San Diego, United States
Employees
135
Open positions
24
Dealroom signal
86.5/100
Industry
Wellness Beauty
Sector
Wellness Beauty, Dietary Supplements, Nutrition
Business model
Manufacturing
Client focus
b2c

Latest news

Press, funding announcements and product moves mentioning Cymbiotika.

See all news

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
GROWTH EQUITY NON VCOther financing Aug 2026 $0 Alix Earle
SEEDEquity / VC Nov 2025 $25M $100M Guy Oseary · Steve Aoki · Post Malone · David Grutman
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearRevenueGrowth
2026
2025
2024
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Cymbiotika website traffic

Latest recorded traffic for Cymbiotika is 940K monthly website visits, up 10.6% over the last three months. Cymbiotika's team grew 20.5% over the past year.

Latest monthly visits940K 3-month web change+10.6% 1-year team growth+20.5%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investors

11 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed9 investors entered at this stage

  • Guy Oseary
  • Steve Aoki
  • Post Malone
  • David Grutman
  • Ryan Tedder
  • Daymond John
  • Marshmello
  • The Weeknd
  • Nyjah Huston

Series B and later2 investors entered at this stage

  • Revtek Capital
  • Alix Earle
Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States98.1%
🇦🇺 Australia0.9%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Cymbiotika on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Cymbiotika’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.